Stephens Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $250
IQVIA Holdings Is Maintained at Buy by B of A Securities
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating, Announces Target Price $261
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $261
IQVIA Hldgs Analyst Ratings
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $235 to $273
IQVIA Holdings: Promising Growth Trajectory and Strategic AI Integration Support Buy Rating
RBC Capital Reiterates Outperform on IQVIA Hldgs, Maintains $270 Price Target
Jefferies Raises Price Target on IQVIA Holdings to $200 From $195
IQVIA Holdings (IQV) Receives a Buy From Evercore ISI
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $212 to $270
IQVIA Holdings (IQV) Receives a Buy From Stifel Nicolaus
Deutsche Bank Adjusts IQVIA Holdings Price Target to $260 From $265, Maintains Buy Rating
IQVIA Holdings Is Maintained at Neutral by Baird
IQVIA Hldgs Analyst Ratings
IQVIA Holdings: Moderate Growth Projections and Neutral Rating Amid Market Expectations
IQVIA Holdings (IQV) Gets a Buy From Barclays
Stifel Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $273
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Novavax (NVAX) and Veeva Systems (VEEV)
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating